VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
43 hedge funds and large institutions have $48.7M invested in Viracta Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 10 closing their positions.
Holders
43
Holders Change
-6
Holders Change %
-12.24%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
11
Reduced
9
Closed
10
Calls
$925K
Puts
$51K
Net Calls
+$874K
Net Calls Change
+$118K
Top Buyers
1 |
OM
1
Opaleye Management
Boston,
Massachusetts
|
$2.26M |
2 |
SCM
2
Sio Capital Management
New York
|
$1.28M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$2.39M |
4 |
BI
4
BVF Inc
San Francisco,
California
|
$6.32M |
5 |
5
BlackRock
New York
|
$339K |